Lin Elizabeth Yeu bought TARS
December 15, 2025 · Form 4 insider transaction
Lin Elizabeth Yeu bought 6,819 shares of Tarsus Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,819
Price
N/A
Total value
N/A
InsiderLin Elizabeth Yeu
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 15, 2025
Filing dateDecember 17, 2025
Shares owned after24,019
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.; Since the date of the Reporting Person's last report, 9,506 shares previously owned by the Reporting Person's Spouse's Roth IRA were transferred to the Reporting Person's self-directed IRA and are now directly owned.